InvestorsHub Logo
Followers 57
Posts 5700
Boards Moderated 0
Alias Born 12/13/2004

Re: None

Sunday, 09/14/2014 11:02:57 AM

Sunday, September 14, 2014 11:02:57 AM

Post# of 346054
I am not worried at all about enrollment. They have already done the hard work getting 136 trial centres set up. That was the hard part. There are many hoops to jump through in every country and in every hospital. Their strategy now is clearly to have an ongoing program of education of key opinion leaders and oncologists.

Anyone can do all the personal research you like but if the oncologist explains why you are wrong and there is a better choice...most people will go with the oncologists recommendation IMO. At least I would! PPHM has been doing this KOL/oncologist approach all the way back to Australia.

Well informed oncologists are Bavi's best friends. They will have the hard data about Bavi's great safety and outstanding MOS results. I believe that they want the best for their patients and the Bavi/taxane data is outstanding in second line NSCLC!

It is only my opinion but I would not be at all surprised to see an approval arising out of the first event driven look-in. This can be debated until the cows come home because none of us even knows whether the number of events for the first look-in is 150 or 200 or 250!

And just as an aside....this huge network of oncologists will be a great advantage for FUTURE BAVI TRIALS IN OTHER INDICATIONS AND WITH OTHER COMBINATIONS!

"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News